期刊
JOURNAL OF CLINICAL IMMUNOLOGY
卷 29, 期 3, 页码 265-273出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10875-009-9283-y
关键词
Myeloid dendritic cells; plasmacytoid dendritic cells; natural killer cell subsets; interleukin-12; interleukin-15; type I interferon; DC/NK cell cross-talk
类别
资金
- Burroughs Wellcome Fund
- Starr Foundation
- National Cancer Institute [R01CA108609, R01CA101741]
- National Institute of Allergy and Infectious Diseases [RFP-NIH-NIAID-DAIDS-BAA-0619]
- Foundation for the National Institutes of Health
- Associazione Italiana Ricerca sul Cancro (AIRC)
- Ministero Italiano della Salute-Programma Straordinario Ricerca Oncologica
- Fondazione Banco di Sicilia
- Regione Sicilia-Ricerca Sanitaria Regionale 2007
- NATIONAL CANCER INSTITUTE [R01CA101741, R01CA108609] Funding Source: NIH RePORTER
In recent years, it has been realized that innate lymphocytes do not act in isolation but potentiate their efficiency by interacting with each other, resulting even in the regulation of adaptive immune response. One such cross-talk exists between dendritic cells (DCs) and natural killer (NK) cells. Here, we summarize recent studies on which subsets of these two innate immune components participate in this interaction, how it influences immune responses, and to which extent similar stimuli are integrated by DCs and NK cells during innate immunity. We suggest that this cross-talk should be harnessed by activating both of these innate leucocyte populations with new adjuvant formulations for immunotherapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据